101¦~8¤ë¸¹ ¹D ªk ªk °T (244)

DEEP & FAR

 

¬ü°êµo©úªk®×(America Invents Act)¡G
¥þ­±©Ê±M§Q§ï­²²{¤µ³Qñ¸p¦¨ªk«ß
James W. Brady, Jr., Jeremy A. Cubert, Ryan H. Flax,
 Charles E. Miller

 

 

ªL ©¾ ±M§Q¤G²Õ°Æ¥D¥ô

¡E      ²MµØ¤j¾Ç¤uµ{»P¨t²Î¬ì¾Ç¨t

 

 

 

2. ¥ý¨Ï¥ÎªÌÅv§Q(prior user rights)

¦b35 U.S.C. ¡±273¤Uªº¥ý¨Ï¥ÎªÌÅv§Q¤§¨¾¿m¡A²{¦b³QÂX±i¨ì¥]§t©Ò¦³±M§Q¡A¦Ó«D¶È¬O°w¹ï°Ó·~¤èªkªº±M§Q¡C³Q§i¥²¶·ÂǥѲM·¡¥B¨ã»¡ªA¤OªºÃÒ¾Ú¨ÓÃÒ©ú¡A¦b¨tª§±M§Q³Ì¦­¥D±iªºÀu¥ýÅv¤é©Î¨ã¦³35 U.S.C. ¡±102(b)¥ý«e§Þ³N¡§Àu´f´Á¡¨¸ê®æªº³Q¥D±iµo©ú¤§³Ì¦­¤½¶}´¦ÅSªº¦Ü¤Ö¤@¦~«e¡A¥L­Ì¦b¬ü°ê¤¤°Ó·~¤W¦a¨Ï¥Î¤F³Q¥D±iªºµo©ú¡C35 U.S.C. ¡±273(a)¡C

Âǥѫإߦw¥þ©M¥\®Ä¨Ó½Ð¨D¤W¥««e³\¥i(premarket approval)¦³¸ê®æ¦¨¬°¡§°Ó·~¨Ï¥Î(commercial use)¡¨¡A¦³¦p¦b«DÀç§Qªº¹êÅç«Ç©Î¹êÅ餤¬ã¨s¤Wªº¨Ï¥Î¥çµM¡C©Î³\¦³ÂI¿Ø¨ë¡A¬°¤Fºû«ù¡§°Ó·~¨Ï¥Î¡¨ªºª¬ºA¡A¦b«DÀç§Qªº¹êÅç«Ç©Î¹êÅ餤ªº¨Ï¥Î¥²¶·¬O¬°¤F¡§«ùÄò¥B«D°Ó·~ªº¨Ï¥Î¡¨¡C

°£¤FÀHµÛ¾ã­Ó¥ø·~ªº²¾Âà¥~¡A¥ý¨Ï¥ÎªÌÅv§Q¬O­Ó¤H¥B¤£¥i³Q²¾Â઺¡C35 U.S.C. ¡±273(e)(1)(B)¡C¯S§O¬O¡A¦pªG¬Y¤j¾Ç´£¥X¹ï§Ü¬Y­ÓÅ骺¶D³^¡A«h¥ý¨Ï¥ÎªÌ¨¾¿m¤£¯à¥Ñ¹ï§Ü¸Ó¤j¾Çªº¸Ó­ÓÅé¨Ó¥D±i¡A°£«D¦³Áp¨¹³\¥i¼·´Ú(federal grant monies)¯A¤Î¨ì¸Ó³Q¥D±i±M§Q¤§¥I½Ñ¹ê¦æ¡C½Ð°Ñ¾\ 35 U.S.C. ¡±273(e)(5)(A)¡C¦pªG¸Ó¨Ï¥Î¬O·½¦Û©ó¸Ó±M§Q©Ò¦³Åv¤H¡A©Î¦pªG¸Ó°Ó·~¨Ï¥Î³Q©ñ±ó¡A«h¸Ó¨¾¿m¤]¬O¤£¥i¨Ï¥Îªº¡C35 U.S.C. ¡±273(e)(5)(B)¡C

¥ý¨Ï¥ÎªÌÅv§Q¥i¯à¬O¤ñ35 U.S.C. ¡±271(e)(1)¤Uªº¦w¥þ´ä±ø´Ú(safe harbor provisions)§ó¬°¼sªx¡A¦ý«o¥]§tÀ³¸Ó³Q¤p¤ßÅU¼{¨ìªº¤@¨Ç¨Ò¥~¡C¥Ø«e¤´µ¥µÛ¬Ý¬O§_¥ý¨Ï¥ÎªÌÅv§QªºÂX±i±N·|¦b¥i±o§Q¥Î¼sªxªº¡§¦w¥þ´ä¡¨±ø´Ú¤U¡A¹ï¥Í©R¬ì¾Ç±M§Q(life sciences patents)»â°ì¤¤¦³¹ê°È¤Wªº½ÄÀ»¡C